Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. (PTGX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PTGX · as of Jun 8, 2026
Key Statistics
Explore Protagonist Therapeutics, Inc. Data
ptgx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 26 · Buy rate: 96.2%
The PTGX analyst consensus is Buy, based on ratings from 26 Wall Street analysts over the past 3 months. The average 12-month price target is $115.40, representing +18.72% upside from the current price of $97.21.
Competitors & Peers
ptgx competitorsPTGX
ACLX
AKRO
ALKS
CRNX
IMVTStock Performance
Full HistoryAbout Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory dis…
what is protagonist therapeutics, inc. · ptgx stock overview · protagonist therapeutics, inc. company profile · who is protagonist therapeutics, inc. ceo · ptgx NASDAQ · protagonist therapeutics, inc. headquarters · protagonist therapeutics, inc. business segments
About Stock Overview & Key Data
Protagonist Therapeutics, Inc. (PTGX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 11, 2016. As of the latest trading session, PTGX stock price is $97.21, with a market capitalization of $6.3B. The stock has returned +74.86% over the past 12 months and +11.47% year-to-date.
According to 26 Wall Street analysts, the consensus rating for Protagonist Therapeutics, Inc. stock is Buy, with an average 12-month price target of $115.40. In fiscal year 2025, Protagonist Therapeutics, Inc. reported revenue of $46.0M and net income of -$130.1M. For detailed data — including Protagonist Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Protagonist Therapeutics, Inc. (PTGX) stock price is $97.21. The stock is traded on NASDAQ under the ticker symbol PTGX. The 52-week range is $49.38 – $107.84.